Description
Indication & Scope
Anastrozole Tablets (Arimidex®) is a highly selective non-steroidal aromatase inhibitor. It can significantly inhibit aromatase activity, block peripheral estrogen synthesis in postmenopausal women, reduce circulating estrogen level, and suppress the proliferation of estrogen-dependent breast tumor cells.
- Mechanism
Selective aromatase inhibitor (AI) - Drug class
Prescription oral endocrine therapeutic agent for breast cancer - Clinical use
Postmenopausal hormone receptor-positive early/advanced breast cancer
| Generic Name | Anastrozole Tablets |
| Brand Name | Arimidex® |
| Ingredient | Anastrozole |
| Dosage Form | Film-coated Tablets |
| Package | 1mg*14 tablets/box |
| Conditions Treated | Adjuvant treatment for hormone receptor-positive early invasive breast cancer in postmenopausal women; First-line treatment for hormone receptor-positive advanced breast cancer in postmenopausal women; Second-line treatment for advanced breast cancer after tamoxifen failure in postmenopausal women |
| Taboos | Pregnant or breastfeeding women |
| Place of origin | Delaware, USA |
| Priscription Type | Prescription Drug |
| Storage Conditions | Sealed, store below 30°C, avoid light |
| Manufacturer | AstraZeneca Pharmaceuticals LP |
| Registration Authority | National Medical Products Administration (NMPA) |
| Approval number | HJ20140691 |
| Approval Date | December 04, 2023 |
| Shelf Life | 60 months |
How to use ?
Recommended Dose: 1 mg orally once daily, taken with or without food. Early breast cancer: Continuous administration for 5 years as adjuvant therapy. Advanced breast cancer: Take continuously until disease progression or intolerable adverse reactions occur.
Time: Fixed daily oral administration at the same time every day; no strict restriction on meal time.
Interaction: Do not co-administer estrogen-containing preparations, which will offset the drug efficacy. Tamoxifen combined use reduces plasma concentration of anastrozole, avoid simultaneous medication.
Side effects: Common: Hot flushes, joint pain/stiffness, fatigue, nausea, headache, osteoporosis, vaginal dryness. Rare: Hepatic function abnormality, rash, diarrhea, hair thinning, increased appetite. Severe risk: Bone fracture, ischemic cardiovascular events.
Important Notice
This product shall only be used for post-exposure rabies prophylaxis by professional medical staff. It must be applied combined with rabies vaccine and injected via wound infiltration plus intramuscular routes as specified. Do not administer intravenously or alter the dosage at will. Hypersensitivity monitoring is required throughout the whole injection process.
Packaging & Shipping
Packaging
Original manufacturer’s packaging with secure export carton. Customized export packaging is available upon request.
Shipping Methods
Express Courier (EMS, DHL, FedEx, UPS), Air Freight, and Sea Freight. Cold-chain transportation is available for products requiring temperature-controlled logistics.
Export Support
Certificate of Analysis
GMP Certificate
Commercial Invoice
Packing List & CPP
Cold Chain Logistics
Customs Documentation
Scientific and regulatory sources
FAQ
What is the core pharmacological effect of anastrozole?
It inhibits aromatase to cut off estrogen production and restrain estrogen-sensitive breast cancer growth.
How long is the adjuvant treatment course for early breast cancer?
Standard continuous oral administration for 5 years.
Can this medicine be used together with estrogen drugs?
No, estrogen medicines will counteract its therapeutic effect.
Which patients are prohibited from using Arimidex?
Pregnant, lactating and premenopausal women, as well as patients allergic to anastrozole.
Arimidex® | Anastrozole Tablets | Breast Cancer | DengYueRX
INN: Anastrozole
Indications: Breast Cancer
Dosage Form: Film-coated Tablets
Strength: 1mg/Tablet
Original price was: $73.99.$62.89Current price is: $62.89.
Low MOQ
WHO-GMP
Worldwide Delivery
Compliance and Regulatory Documents
Related Products
